Trials / Unknown
UnknownNCT04364347
Chemotherapy-induced Circadian Rhythm Disruption
Chemotherapy-induced Circadian Rhythm Disruption: Investigation Using Biomarker
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 27 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate chemotherapy-induced circadian rhythm disruption through biomarkers, and the relationship between chemotherapy-induced circadian rhythm disruptions and side effects of chemotherapy.
Conditions
Timeline
- Start date
- 2019-12-14
- Primary completion
- 2022-10-01
- Completion
- 2023-02-01
- First posted
- 2020-04-28
- Last updated
- 2022-05-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04364347. Inclusion in this directory is not an endorsement.